
EVO vs SLN
$EVO vs $SLN head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
EVO vs SLN: the quick read
- ·SLN is the larger company by market cap ($591M vs $573M).
- ·SLN has been more active on our scanner (92 vs 16 alerts in 30 days).
- ·SLN has the smaller float (89.5M vs 342.4M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·EVO trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·SLN draws far more of our scanner's attention, 92 unusual-volume alerts in 30 days against 16, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
- ·EVO pays a dividend and SLN does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing EVO and SLN on TheDesperateTrader.
- Is EVO or SLN the better stock?
- "Better" depends on your goal, and these two are not alike. SLN is the larger company by market cap ($591M vs $573M). SLN has been more active on our scanner (92 vs 16 alerts in 30 days). SLN has the smaller float (89.5M vs 342.4M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between EVO and SLN?
- The differences that matter: they are not in the same business - EVO is pharmaceutical preparations and SLN is pharmaceutical preparations; they are similar in size ($573M vs $591M); they trade at very different share prices ($1.61 vs $9.82); EVO sits at 4% of its 52-week range against 42% for SLN; only EVO pays a dividend; our scanner flagged EVO 16 times in the last 30 days against 92 for SLN. Everything above is measured from the latest completed session and SEC filings.
- Which of EVO and SLN is more active right now?
- Right now EVO is at about 0.7x its normal volume and SLN is at about 1.6x, so SLN is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading EVO or SLN? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore EVO and SLN comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.